Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet (British edition), 2010-08, Vol.376 (9742), p.687-697 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 28-Sep 3, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61121-X ;PMID: 20728210 ;CODEN: LANCAOFull text available |